Anu Chawla/LinkedIn
Jun 29, 2026, 11:44
Anu Chawla: PICSI in Focus, What the HABSelect Trial Revealed?
Anu Chawla, Chairperson at Federation of obstetrics and Gynaecological Societies of India, shared a post on LinkedIn:
- The HABSelect Trial is the largest randomised study evaluating PICSI.
- It included 2,722 couples across 16 UK fertility centres.
- PICSI did not significantly improve overall live birth rates compared with standard ICSI.
- PICSI was associated with a lower miscarriage rate (14% vs 22%), representing approximately a 38% relative reduction.
- Current international guidelines do not recommend routine PICSI for every patient, but selected individuals may benefit.
- Treatment decisions should always be personalised following discussion with a fertility specialist.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 3, 2026, 18:27Non-Invasive Prenatal Testing: Science, Counselling, Global Access and Equity – IJGO
-
Oct 3, 2026, 18:19Erica Marsh: Congratulations to the 4 Doctors Who Were Named 2026 Top Docs by Hour Detroit Magazine
-
Oct 3, 2026, 18:16Shizuko Takahashi: What about the “Biological Clock” in Men?
-
Oct 3, 2026, 18:11Devyanshi Dixit: Call for Speakers for GFWH 2026
-
Oct 3, 2026, 18:06Shaun Greenaway: The More We Understand Male Fertility, the Better Decisions We Can Make
-
Oct 3, 2026, 17:55Reproductive BioMedicine Online’s Latest Issue, 53.4, Is Out
-
Oct 3, 2026, 17:50Ananya Anand Kumar: Excited to Share that My Cryopreservation Abstract Was Accepted for Fertility 2027
-
Oct 3, 2026, 17:48Pregnancy of the Future: Predicting, Preventing, and Treating the Great Obstetric Syndromes – SMFM
-
Oct 3, 2026, 17:46PMOS Was Never Just About the Ovaries… – PCOS Awareness Association